"PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022" Published
GlobalData has released its new Country report, "PharmaPoint: HIV - Japan Drug Forecast and Market Analysis to 2022". Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a deadly disease to a manageable chronic condition for most infected individuals. Antiretroviral treatment not only reduces the viral load and reconstitutes immune function, but also decreases infection incidence rates by...
View full press release